No insider open-market trades in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsEach bar is 100% of that source’s money. The notch marks an even split.
Lean is the direction of the latest moves. Descriptive, not advice.
Buys (1)
Markscheid Stephen
$50K
bought
Sells (2)
Siew Wing Keong
$264K
sold
Li Xianhua
$32.7M
sold
No tracked top-trader positions in JKS as of Oct 24, 07:12 UTC.
Hyperliquid positioning - not every stock is covered
Last report
Aug 26, 2026
Period ending
Jun 30, 2026
Earnings per share
-$0.75 expected
Revenue
Financial statements: Alpha Vantage
| Period ending | Reported | EPS / estimate | EPS surprise | Revenue / income | Surprise |
|---|---|---|---|---|---|
| Jun 30, 2026 | Aug 26, 2026 | -$2.53 / -$0.75Alpha Vantage | -$1.78 miss | CNY 12.32B No estimate | Unavailable |
| Mar 31, 2026 | Apr 29, 2026 | -$4.20 / -$0.89Alpha Vantage | -$3.31 miss | CNY 12.25B No estimate | Unavailable |
| Dec 31, 2025 | Mar 25, 2026 | -$4.20 / -$0.31Alpha Vantage | -$3.89 miss | CNY 17.27B No estimate | Unavailable |
| Sep 30, 2025 | Nov 17, 2025 | -$2.01 / -$2.01Alpha Vantage | +0.00% in line | CNY 16.16B No estimate | Unavailable |
| Jun 30, 2025 | Sep 26, 2025 | -$11.25 / -$15.68Alpha Vantage | +28.25% beat | $2.49B No estimate | Unavailable |
| Mar 31, 2025 | Apr 29, 2025 | -$2.64 / -$1.31Alpha Vantage | -101.53% miss | $13.84B No estimate | Unavailable |
| Dec 31, 2024 | Mar 26, 2025 | -$1.28 / -$3.96Alpha Vantage | +67.61% beat | CNY 20.65B No estimate | Unavailable |
| Sep 30, 2024 | Oct 30, 2024 | $0.09 / -$0.29Alpha Vantage | +131.03% beat | $24.51B No estimate | Unavailable |
EPS uses Yahoo Finance where available, then Alpha Vantage or verified release comparisons. Revenue and income use company releases, SEC filings, Alpha Vantage or Yahoo Finance. Non-USD revenue carries its currency code. Comparisons require a paired release estimate.
| USD | Sep 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|
| What came in | |||
| Revenue | $24.51B | $13.84B | $2.49B |
| Cost of what it sold | $20.65B | $14.20B | $2.41B |
| Gross profit | $3.86B | -$352.9M | $72.8M |
| What it spent | |||
| Research and development | $208.7M | $151.8M | $34.8M |
| Sales and admin | $1.18B | $1.22B | $401.8M |
| Other operating costs | $2.40B | $609.5M | -$176.6M |
| Total operating expenses | $3.78B | $1.98B | $260.0M |
| What was left | |||
| Operating profit | $75.5M | -$2.33B | -$187.2M |
| Interest on debt | $294.3M | $341.6M | $46.0M |
| Profit before tax | $154.2M | -$2.76B | -$233.6M |
| Tax | $148.5M | -$699.5M | -$39.9M |
| Net profit | $22.5M | -$1.32B | -$121.2M |
| EBITDA | $458.6M | -$2.37B | -$187.2M |
This stock is under pressure.
Trend
Under pressure
0 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace